{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:17:37Z","timestamp":1783477057920,"version":"3.55.0"},"posted":{"date-parts":[[2026,7,8]]},"group-title":"In Review","reference-count":0,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,6,26]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  <bold>Background<\/bold>\n                  \u03b1-Synucleinopathies are clinically and biologically heterogeneous disorders lacking reliable biomarkers to assist with early diagnosis, disease progression, patient stratification, and therapeutic targeting. Genetic variation is known to impact biomarker levels, influencing their utility and interpretation in research and clinical settings. We aimed to identify common genetic modulators of biomarker levels implicated in \u03b1-synucleinopathy pathogenesis.\n                  <bold>Methods<\/bold>\n                  63 CSF, plasma, and urine biomarkers were analyzed in 581 individuals from the Parkinson\u2019s Progression Markers Initiative (PPMI). GWAS was performed to test for associations with common variants, while regressions and area under the curve (AUC) analysis was used to assess predictive power. Analyses were adjusted for age, sex, disease status, and principal components. PD- and DLB-risk loci associations were separately assessed for each GWAS.\n                  <bold>Results<\/bold>\n                  We confirm strong associations between urine bis(monoacylglycerol)phosphate (BMP) isoforms and the variants\n                  <italic>LRRK2<\/italic>\n                  p.G2019S and\n                  <italic>GBA1<\/italic>\n                  p.N370S, while providing support for BMPs use as a\n                  <italic>LRRK2<\/italic>\n                  -PD biomarker. CSF A\u03b2 was significantly associated with an\n                  <italic>APOE<\/italic>\n                  \u03b54 allele, reinforcing its central role in amyloid regulation. Novel associations were detected between CSF ceramide isoforms the\n                  <italic>MCF2L2<\/italic>\n                  and\n                  <italic>GMNN<\/italic>\n                  loci, and between CSF tau and the\n                  <italic>TP63<\/italic>\n                  locus. Multiple PD risk loci, including\n                  <italic>MAPT<\/italic>\n                  ,\n                  <italic>SIPA1L2<\/italic>\n                  ,\n                  <italic>MCCC1<\/italic>\n                  , and\n                  <italic>RAB29<\/italic>\n                  , were associated with lysosomal lipid biomarkers, highlighting pathway-level convergence.\n                  <bold>Conclusions<\/bold>\n                  The present study reveals established and novel genetic modulators of potential \u03b1-synucleinopathy biomarkers, demonstrating that genetic background significantly shapes biomarker levels. These genetic influences should be accounted for when conducting biomarker-based research, clinical trials, or therapeutic development to ensure accurate interpretation and improve their translational relevance.\n                <\/p>","DOI":"10.21203\/rs.3.rs-10165954\/v1","type":"posted-content","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:55:40Z","timestamp":1783475740000},"source":"Crossref","is-referenced-by-count":0,"title":["Genome-wide association studies identify genetic determinants of synucleinopathy biomarkers.\u00a0"],"prefix":"10.21203","author":[{"given":"Emma N.","family":"Somerville","sequence":"first","affiliation":[{"name":"The Neuro (Montr\u00e9al Neurological Institute-Hospital), McGill University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lang","family":"Liu","sequence":"additional","affiliation":[{"name":"The Neuro (Montr\u00e9al Neurological Institute-Hospital), McGill University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ta","sequence":"additional","affiliation":[{"name":"Center for Alzheimer's and Related Dementias, USA Laboratory of Neurogenetics, National Institute on Aging"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Iwaki","sequence":"additional","affiliation":[{"name":"Center for Alzheimer's and Related Dementias, USA Laboratory of Neurogenetics, National Institute on Aging"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Senkevich","sequence":"additional","affiliation":[{"name":"The Neuro (Montr\u00e9al Neurological Institute-Hospital), McGill University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy N.","family":"Alcalay","sequence":"additional","affiliation":[{"name":"Department of Neurology, Columbia University Irving Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziv","family":"Gan-Or","sequence":"additional","affiliation":[{"name":"The Neuro (Montr\u00e9al Neurological Institute-Hospital), McGill University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10165954\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10165954\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:55:46Z","timestamp":1783475746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10165954\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":0,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-10165954\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,7,8]]},"subtype":"preprint"}}